Medical hashish improves the effectiveness of fibromyalgia therapies, research outcomes – firebird-cbdoil


A new research study found that medical cannabis can improve the effectiveness of standard analgesic treatments against fibromyalgia.

Fibromyalgia (FM) is a disease which is characterized by widespread pain in the musculoskeletal system and which often occurs in addition to sleep and mood disorders, fatigue and memory problems. Many patients with FM also suffer from TMJ, anxiety, depression, tension headache, and irritable bowel syndrome. There is currently no cure for FM, and doctors generally recommend using over-the-counter pain relievers to treat muscle stiffness and pain associated with this condition.

Recent research suggests that cannabis can help treat chronic pain, inflammation, sleep disorders, and other conditions that most FM patients suffer from. Many previous studies have found that medical cannabis can be an effective alternative to traditional pain relievers, but the present study suggests that cannabis can actually increase the effectiveness of standard treatments.

Researchers from the rheumatology departments of five Italian medical facilities recruited 102 FM patients who had not previously responded well to conventional medical treatments. Each of these subjects received one of two medicinal cannabis oil extracts: Bedrocan, a formula that contains 22 percent THC but less than one percent CBD; and Bediol, an oil that contains 6.3 percent THC and 8 percent CBD.

Over the course of six months, patients received a series of standard questionnaires to assess their FM symptoms, general fatigue and sleep quality. Patients were also asked to self-report their depression and anxiety using standard psychological rating scales. During the study, patients were allowed to either lose weight or stop using the standard analgesics they were taking to treat their symptoms.

The study, which was just published in the Clinical and Experimental Rheumatology Journal, reports that half of the patients had fewer symptoms of depression and anxiety after taking cannabis oils. Only a third of the subjects reported that cannabis treatments improved their FM symptoms, but 44 percent of the patients reported improvements in their overall sleep quality. In addition, 47 percent of the subjects were able to reduce the use of standard analgesics or even stop using them entirely.

The authors of the study concluded that medical cannabis therapy [MCT] "offers a possible clinical advantage in FM patients, especially in patients with sleep disorders … The retention rate and changes in the simultaneous analgesic therapy reflect the MCT effectiveness of the improved quality of patient life. "

Due to the small subject size and the observational nature of the study, the researchers recommend that further clinical studies be carried out in order to “confirm these data, identify subgroups of FM patients responding to MCT and determine the most suitable posology and duration of the Therapy. ”